Key Laboratory of Chemical Biology, Ministry of Education, Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
National Glycoengineering Research Center, Cheeloo College of Medicine, Shandon University, Jinan, 250012, Shandong, China.
Biomater Sci. 2023 Aug 22;11(17):5970-5983. doi: 10.1039/d3bm00713h.
The shortage of corneal donors has prompted the development of tissue-engineered corneal grafts as an alternative solution. Currently, amniotic membranes with good biocompatibility are widely used as scaffolds for loading stem cells in the treatment of corneal injury. However, this approach has its limitations. In this study, BMSCs were induced to differentiate into corneal epithelial cells direct contact co-culture, and platelet-poor plasma was used to prepare fibrin gels, which were compressed to remove excess liquid and then lyophilized to obtain plasma fibrin membranes (PFMs). A tissue-engineered corneal implant with PFMs as a scaffold loaded with BMSCs and corneal epithelial cells was designed and obtained. Scanning electron microscopy showed that PFMs have a uniformly distributed microporous surface that facilitates cell attachment and nutrient transport. The rheological results showed that the freeze-dried and rehydrated PFMs were more rigid than fresh membranes, which makes it easier to use them for transplantation after cell loading. The experimental results of a rat alkali burn cornea injury model showed that PFMs effectively reduced the inflammatory reaction, inhibited fibrosis, and accelerated the healing of corneal wounds. It was also found that some of the BMSCs were successfully implanted into the corneal injury site in rats and differentiated into corneal epithelial cells. These results demonstrate the potential of tissue-engineered corneal implants using BMSCs and corneal epithelial cells and PFMs as scaffolds as a new treatment option for corneal injury.
角膜供体短缺促使人们开发组织工程化角膜移植物作为一种替代解决方案。目前,具有良好生物相容性的羊膜被广泛用作负载干细胞治疗角膜损伤的支架。然而,这种方法存在局限性。在本研究中,通过直接接触共培养将 BMSCs 诱导分化为角膜上皮细胞,并用富血小板血浆制备纤维蛋白凝胶,将其压缩去除多余液体,然后冻干获得等离子体纤维蛋白膜(PFMs)。设计并获得了一种以 PFMs 为支架的组织工程化角膜植入物,支架上负载 BMSCs 和角膜上皮细胞。扫描电子显微镜显示,PFMs 具有均匀分布的微孔表面,有利于细胞附着和营养物质运输。流变学结果表明,冻干和复水后的 PFMs 比新鲜膜更硬,这使得在细胞负载后更容易进行移植。大鼠碱烧伤角膜损伤模型的实验结果表明,PFMs 有效减轻了炎症反应,抑制了纤维化,并加速了角膜伤口的愈合。还发现一些 BMSCs 成功植入大鼠角膜损伤部位并分化为角膜上皮细胞。这些结果表明,使用 BMSCs 和角膜上皮细胞以及 PFMs 作为支架的组织工程化角膜植入物具有作为角膜损伤新治疗选择的潜力。